[Aha Latin] Sambucus nigra

[Nkọwa] Anthocyanidins15% 25% UV

[ọdịdị] ntụ ntụ na-acha odo odo

Akụkụ Osisi Eji: Mkpụrụ osisi

[Nha irighiri ihe] 80 Mesh

[Mfu na ihicha] ≤5.0%

(Heavy Metal) ≤10PPM

[Nchekwa] Chekwaa n'ebe dị jụụ & nke kpọrọ nkụ, zere ọkụ ozugbo na ikpo ọkụ.

[Ndụ nchekwa] Ọnwa iri abụọ na anọ

[Ngwugwu] Ajujuru na ịgbà akwụkwọ na akpa rọba abụọ n'ime.

[Net arọ] 25kgs / drum

[Gịnị bụ ewepụtara elderberry?]

Elderberry wepụ sitere na mkpụrụ nke Sambucus nigra ma ọ bụ Black Elder, ụdị dị na Europe, Western Asia, North Africa, na North America. A na-akpọ "igbe ọgwụ nke ndị nkịtị," Elder okooko osisi, tomato, epupụta, ogbugbo, na mgbọrọgwụ ejirila ọtụtụ narị afọ na ọgwụ ndị mmadụ. amino asịd. Ekwenyere na Elderberry nwere ojiji ọgwụgwọ dịka mgbochi mkpali, diuretic, na immuno-stimulant.

[ọrụ]

1. Dị ka ọgwụ akụrụngwa: Ọ nwere ike ịkwalite ọgwụgwọ ọnya afọ; Enwere ike iji ya maka ịba ọcha n'anya na-adịghị ala ala na ịba ọcha n'anya hepatomegaly, hepatocirrhosis; kwalite ọgwụgwọ ọrụ imeju.

2. Dị ka nri colorant: A na-eji ya na achịcha, ihe ọṅụṅụ, swiiti, ice cream wdg.

3. Dị ka chemical akụrụngwa maka kwa ụbọchị: A na-eji ya n'ọtụtụ ụdị ọgwụ eze ndụ akwụkwọ ndụ na ihe ntecha.

Nke a bụ ndepụta ndị mmadụ….
Methadone-ọnụ 80-90%, ọkara ndụ - awa 24-36, rectal 76%
Ọnụ ọnụ Ketobemiodone bụ 34% +/-10%, n'ụzọ ziri ezi 44% +/- 9%, ọkara ndụ bụ awa 2.25-2.45
Meperidine rectal bioavailability bụ ihe dịka 55%, 80% ruo 85% IM, mkpochapụ ọkara ndụ 3.0 h.
Buprenorphine nwere nnukwu protein jikọtara 96%, bioavailability sublingual bụ ihe dịka 30%, ọnụ bụ 15-22%, 90-100% IM, nkwụsị ọkara ndụ bụ awa 12-44.
Hydromorphone- 5-8 ugboro dị ike dị ka morphine, intranasal- 52.4%, Rectal Administration 33% ,Oral-30-35%, (na-akọkwa dị ka 50.7% +/- 29.8% ọnụ; 33% +/- 22% rectal; 54.4% - 59.8% imi)
Dihydrocodeine ọnụ-20-21% ọkara ndụ awa 4
Ọnụ ọnụ Heroin ~ 35% IV- 100% IM-85% Sụrụ anwụrụ (ma ọ bụ vaporized?) 52-55% vaporized Semisynthetic derivative, Intranasal 44-61%
Fentanyl- Bioavailability 92% (transdermal), 50% (sublingual/buccal (megide ntì), Protein na-ejikọta 80-85%, ọkara ndụ 3-12 awa.
Sufentanil intranasal bio- 78%,
Remifentanil Protein na-ejikọta 70% (jide na protein plasma) Ọkara ndụ 1-20 nkeji
Alfentanil- IV ~ 100%, njikọ protein 92%, ọkara ndụ bụ awa 1.5-2.
Morphine ~ 32% onu / rectal, insuffulated- 15-20%, Chitosan (a linear polysaccharide nke na-enyere aka ịmịnye ọgwụ nke ọma) egosila ịbawanye bioavailability imi nke morphine site na gburugburu 10-20% ruo n'elu 60%, SC-60% , protein njikọ 30-40%, ọkara ndụ bụ 2-3 awa
Oxycodone-ọnụ 60-87% intranasal- dịgasị iche iche 45-70%
Hydrocodone-ọnụ bioavailability amabeghị n'ezie mana ọ dị gburugburu oxycodone bioavailability, ~ 70% nke ya na-etinyekarị uche, ọkara ndụ bụ awa 4-8.
Oxymorphone imi bioavailabilty [43%] ọnụ ọnụ ala 10-20%
Butorphanol - ọnụ 5-17% n'ihi elu mbụ ngafe metabolism
Tramadol- bioavailability zuru oke nke tramadol nke enwetara n'ime nri bụ 77.0%, Oral-68-72% (na-abawanye site na doses ugboro ugboro) ọkara ndụ awa 5-7.
Codeine - na-esote nchịkwa ma ọ bụ nchịkwa ọnụ yana ihe dị ka 90% nke sistemu; N'otu akwụkwọ nyocha dịgasị iche iche ugboro 4 yana nnweta sistemu mgbe usoro onunu gasịrị dị n'etiti 50 na 84%
Diphenoxylate Protein na-ejikọta 74-95% Ọkara ndụ 12-14 awa ejiri maka afọ ọsịsa, (anaghị agafe ihe mgbochi ụbụrụ ọbara nke ọma)
Pethidine (meperidine) absorption bioavailability ọnụ bụ 50-60% n'ime ndị ọrịa nwere ọrụ imeju nkịtị. IM 80-85%, Protein Jide 65-75%, Ọkara Ndụ 3-5 awa
Normeperidine dị ihe dị ka ọkara nke ike dị ka meperidine, mana ọ nwere mmetụta mkpali CNS ugboro abụọ.
Pentazocine- Bioavailability ~ 20% ọnụ, Ọkara ndụ 2 ruo 3 awa

Ndị na-emegide opiate
Naloxone onu- 2-4% (90% absorption ma elu mbụ ngafe metabolism), Ọkara ndụ 1-1.5 awa
Naltrexone Oral Bioavailability 5-40%, Protein na-ejikọta 21%, Ọkara ndụ-4 awa (naltrexone),
na awa 13 (6-β-naltrexol) (metabolite)

OMS bụ mmemme ibi ndụ dị mma nke na-achọ inyere ndị mmadụ aka ibi ogologo ndụ ahụike na-enweghị nsogbu ọ bụla metụtara Multiple Sclerosis. OMS dabere na nyocha sayensị siri ike. Maka nkọwa ndị ọzọ gbasara mmemme OMS, lee www.overcomingms.org na akwụkwọ Prọfesọ George Jelinek, 'Imeri Multiple Sclerosis'.